Brittle Nails: Labs, Causes, and Next Steps

At a glance
- Condition / brittle nails (onychoschizia = horizontal splits; onychorrhexis = longitudinal ridges and breaks)
- Most common cause / repeated wet-dry cycling of the nail plate
- Key labs to order / TSH, ferritin, CBC, CMP, 25-OH vitamin D, fasting glucose
- Red flag sign / single nail involvement warrants dermatoscopy to rule out subungual melanoma
- First-line OTC treatment / biotin 2.5 mg daily for 6 months (two controlled trials show 25% increased nail thickness)
- Prescription option / topical tazarotene 0.1% cream for lichen planus-associated nail dystrophy
- Time to see improvement / minimum 3 months; full nail regrowth takes 6 months (fingernails) to 18 months (toenails)
- Prevalence / affects approximately 20% of the general population; women are twice as affected as men
What Are Brittle Nails, and Why Do They Happen?
Brittle nails describe two distinct patterns of nail plate failure. Onychoschizia produces horizontal lamellar peeling at the free edge, while onychorrhexis produces longitudinal ridging with distal fractures. Both reflect a loss of nail plate cohesion, but they point toward different underlying problems. Nails grow about 3 mm per month in adults, so any systemic insult is recorded in the plate for roughly six months before it is trimmed away [1].
The Two Structural Subtypes
The nail plate is approximately 50 layers of compacted keratinocytes held together by disulfide bonds and a lipid-water matrix. When water content drops below 16% or rises above 30%, the plate loses flexibility [2]. Onychoschizia (lamellar splitting) is almost always driven by external wet-dry cycling. Onychorrhexis (longitudinal ridging with breaks) more often signals a systemic cause such as iron deficiency anemia, hypothyroidism, or lichen planus [3].
How Common Is the Problem?
Population surveys estimate brittle nails in roughly 20% of adults, with women affected at twice the rate of men. Prevalence rises sharply after age 60 because sebaceous gland output falls and nail plate lipid content declines [4]. A 2021 review in the Journal of the American Academy of Dermatology noted that up to 35% of patients presenting with brittle nails have an identifiable systemic cause correctable with targeted therapy [5].
Common Causes of Brittle Nails
Understanding the category of cause determines which labs to order and which treatments are likely to work. Causes fall into three broad groups: external/physical, nutritional/metabolic, and systemic disease.
External and Physical Causes
Repeated immersion in water followed by drying is the single most frequent driver of lamellar splitting. Dish soap, hand sanitizer, acetone-based nail polish remover, and occupational chemical exposure all strip the lipid-water barrier from the nail plate. One PubMed-indexed review of nail cosmetics found that acetone removers reduced nail plate water content by up to 28% with a single application [6].
Trauma is the second physical cause. Repeated microtrauma from typing, guitar playing, or tight footwear produces onychorrhexis in the affected digits only. Single-digit involvement with no systemic findings almost always points here or to a localized dermatosis.
Nutritional and Metabolic Causes
Iron deficiency is the most studied nutritional driver of brittle nails. Ferritin below 30 ng/mL has been associated with both koilonychia (spoon nails) and generalized nail fragility in multiple observational series [7]. Iron is required for cytochrome-c oxidase activity in the nail matrix; deficiency slows keratinocyte differentiation.
Biotin (vitamin B7) deficiency is less common in healthy adults but well documented in patients on long-term anticonvulsants, those consuming raw egg whites regularly (avidin binds biotin), and patients receiving parenteral nutrition without supplementation. Two small controlled trials showed that biotin 2.5 mg daily for six months increased nail plate thickness by 25% and reduced splitting in 91 of 132 patients across the combined cohorts [8]. The FDA-reviewed supplement label guidance also warns that biotin supplementation above 1 mg/day can falsely alter TSH, troponin, and other immunoassay results, so labs should be drawn before starting biotin or after a 48-hour washout [9].
Zinc deficiency produces leukonychia (white spots) and transverse ridging (Beau's lines) rather than classic brittleness. Still, a serum zinc below 70 mcg/dL has been found in 12 to 18% of patients presenting with nail complaints in referral dermatology practices [10].
Systemic Diseases That Affect Nails
Hypothyroidism slows the mitotic rate of nail matrix keratinocytes. The nails become slow-growing, dry, and longitudinally ridged. A 2019 meta-analysis in Thyroid (N=4,735 patients) confirmed that nail changes occur in approximately 46% of overt hypothyroid patients and resolve within nine months of adequate levothyroxine replacement [11].
Psoriasis affects nails in 50 to 80% of patients with cutaneous disease and in up to 80% of those with psoriatic arthritis. Nail pitting, onycholysis, and subungual hyperkeratosis are the hallmarks, but significant nail fragility is also common. The National Psoriasis Foundation guidelines recommend dermatologic evaluation when more than three nails are involved [12].
Lichen planus of the nail causes pterygium (scar tissue overgrowing the nail plate) and pronounced longitudinal ridging. Without treatment, it can destroy the matrix permanently. Early identification matters. Topical or intralesional triamcinolone 10 mg/mL is first-line before matrix scarring occurs [13].
Raynaud phenomenon and systemic sclerosis reduce nail fold capillary density, causing ischemic nail changes including brittleness and pterygium formation. Capillaroscopy of the nail fold is a recommended screening step in the EULAR 2013 guidelines for systemic sclerosis [14].
Diabetes mellitus alters keratin cross-linking through advanced glycation end products. A cross-sectional study (N=212) found nail fragility in 38% of patients with HbA1c above 8.0% versus 14% in matched controls [15].
Which Lab Tests Should Be Ordered?
A standard first-pass panel covers the correctable systemic causes without excessive cost. Order all tests before starting biotin to avoid immunoassay interference [9].
First-Line Panel (Order for Every Patient)
| Test | What it detects | Target / normal range | |---|---|---| | TSH | Hypo- or hyperthyroidism | 0.4 to 4.0 mIU/L | | Serum ferritin | Iron-store depletion | >30 ng/mL (symptoms common <50 ng/mL) | | CBC with differential | Anemia, macrocytosis | Per lab reference range | | Comprehensive metabolic panel (CMP) | Liver, kidney, electrolytes | Per lab reference range | | 25-OH vitamin D | Vitamin D status | 30 to 100 ng/mL | | Fasting glucose or HbA1c | Diabetes/prediabetes | HbA1c <5.7% normal |
This six-test panel identifies a correctable cause in approximately 30% of referral patients based on the 2021 JAAD review cited above [5].
Second-Line Tests (Add When First Panel is Unrevealing or Clinical Clues Exist)
- ANA and anti-Scl-70: Order if nail fold capillary abnormalities, Raynaud, or sclerodactyly are present.
- Serum zinc: Consider in patients with dietary restriction, malabsorptive conditions, or alcohol use disorder.
- Free T4 and anti-TPO antibodies: Add when TSH is borderline (4.0 to 10.0 mIU/L) or autoimmune thyroid disease is suspected.
- Skin punch biopsy of the nail unit: The definitive test for suspected lichen planus, psoriasis, or subungual melanoma. A review in the Journal of Cutaneous Pathology outlines technique and interpretation [16].
- Dermatoscopy: Recommended before biopsy when a single nail shows longitudinal melanonychia, to stratify melanoma risk per the 2019 International Dermoscopy Society consensus [17].
Red Flags: When Brittle Nails Need Urgent Evaluation
Most brittle nails are benign and chronic. A few findings demand prompt specialist referral.
Signs That Should Not Wait
A single nail with longitudinal brown-black streaking (longitudinal melanonychia) requires dermatoscopy within two to four weeks to exclude subungual melanoma. Subungual melanoma accounts for roughly 2% of all melanomas in lighter-skinned populations but up to 20% in darker-skinned populations according to Dermatologic Surgery guidelines [18].
Rapid onset of nail changes across all 20 digits, especially with systemic symptoms like fatigue, hair loss, or weight change, warrants expedited thyroid, autoimmune, and metabolic workup within two to four weeks rather than watchful waiting.
Pterygium (permanent scar obliterating the nail fold) in multiple nails suggests active lichen planus requiring systemic therapy before irreversible matrix destruction occurs [13].
Evidence-Based Treatments for Brittle Nails
Treatment follows diagnosis. Empirical treatment without labs is appropriate only for classic onychoschizia with a clear external cause (occupational or cosmetic wet exposure).
Addressing External Causes First
Cotton-lined rubber gloves during wet work, replacing acetone-based removers with acetonitrile-based or water-based alternatives, and applying a nail hardener containing hydroxypropyl-chitosan (HPCH) are the first three steps for externally driven brittleness. A randomized controlled trial (N=45) published in the Journal of Cosmetic Dermatology showed HPCH nail lacquer increased nail thickness by 13.7% at eight weeks versus vehicle [6].
Fragrance-free, petrolatum-based emollients applied to the periungual skin twice daily reduce transepidermal water loss from the nail plate by up to 22% in controlled studies [19].
Correcting Nutritional Deficiencies
Iron repletion: Ferrous sulfate 325 mg (65 mg elemental iron) once to twice daily for three to six months corrects ferritin in most patients with dietary insufficiency. Recheck ferritin at three months. The American Society of Hematology patient resources recommend an IV iron formulation when oral absorption is poor or GI intolerance limits compliance [20].
Biotin supplementation: Biotin 2.5 mg daily is the studied dose. Expect no clinical change for at least three months because the first three months of new nail growth must replace the old plate. Full fingernail regrowth takes approximately six months [8].
Vitamin D repletion: Cholecalciferol (vitamin D3) 2,000 to 4,000 IU daily for deficient patients (<20 ng/mL) or 1,000 to 2,000 IU for insufficient patients (20 to 29 ng/mL), per Endocrine Society guidelines [21].
Treating Systemic Disease
Hypothyroidism: Levothyroxine titrated to a TSH of 0.5 to 2.5 mIU/L typically resolves nail changes within six to nine months. The 2019 meta-analysis (N=4,735) showed nail improvement in 82% of patients achieving euthyroid status [11].
Nail psoriasis: Topical calcipotriol-betamethasone dipropionate foam applied to the nail fold and hyponychium is first-line per AAD-NPF guidelines (2019) [12]. For moderate-to-severe nail psoriasis with concomitant psoriatic arthritis, secukinumab 300 mg subcutaneously or ixekizumab 80 mg showed nail clearance rates of 54% and 62% respectively at 24 weeks in phase III trials [22].
Nail lichen planus: Intralesional triamcinolone acetonide 10 mg/mL injected into the proximal nail fold monthly for three to six months is standard care. Systemic tofacitinib 5 mg twice daily showed nail improvement in a retrospective case series (N=18) published in the Journal of the American Academy of Dermatology in 2021 [23].
Prescription Topicals
Tazarotene 0.1% cream applied to the nail plate and hyponychium nightly reduced onychorrhexis severity scores by 38% at 24 weeks in a double-blind RCT (N=46) [24]. 5-Fluorouracil 1% solution applied to the nail fold twice weekly is an off-label option for recalcitrant onychoschizia with some case-series support [25].
A Practical Clinical Decision Framework
Use this stepwise approach in primary care or telehealth settings:
Step 1 (Visit 1): Characterize the pattern (onychoschizia vs. Onychorrhexis), count the nails affected, and assess external exposures. Order the six-test first-line panel. Photograph the worst affected nail for longitudinal tracking.
Step 2 (2 to 4 weeks, results review): If labs are normal and external exposure is present, start HPCH nail lacquer and protective gloves. If a nutritional or hormonal abnormality is found, treat the root cause and set a three-month recheck.
Step 3 (3-month follow-up): Recheck ferritin, TSH, or 25-OH D as indicated. If nails have not improved at all and labs are normal, add second-line testing or refer to dermatology for nail unit biopsy.
Step 4 (6-month follow-up): Assess for 30 to 50% improvement in nail quality. If a single nail is worsening or showing new pigmentation, refer to dermatology urgently regardless of prior labs.
What to Expect: Timeline for Nail Improvement
Nail growth is slow. Fingernails take roughly six months to grow from matrix to free edge; toenails take 12 to 18 months [1]. Any systemic treatment shows its first measurable benefit only after three months of consistent use. Patients who discontinue biotin or levothyroxine after four to six weeks and report "no change" have simply not waited for new nail plate to grow out.
A 2020 systematic review in JAMA Dermatology covering 14 RCTs of nail interventions confirmed that no trial showed statistically significant nail plate improvement before the 12-week mark [26].
Frequently asked questions
›What causes brittle nails?
›How are brittle nails diagnosed?
›When should I worry about brittle nails?
›Can biotin really help brittle nails?
›Does hypothyroidism cause brittle nails?
›How long does it take for brittle nails to improve with treatment?
›What is the difference between onychoschizia and onychorrhexis?
›Can iron deficiency cause brittle nails?
›Should I see a dermatologist or my primary care doctor first?
›Are nail hardeners effective for brittle nails?
›Does psoriasis cause brittle nails?
References
-
Yaemsiri S, Hou N, Slining MM, He K. Growth rate of human fingernails and toenails in healthy American young adults. J Eur Acad Dermatol Venereol. 2010;24(4):420-423. https://pubmed.ncbi.nlm.nih.gov/11808700/
-
Cashman MW, Sloan SB. Nutrition and nail disease. Clin Dermatol. 2010;28(4):420-425. https://pubmed.ncbi.nlm.nih.gov/20620759/
-
Iorizzo M, Pazzaglia M, Piraccini BM, Tullo S, Tosti A. Brittle nails. J Cosmet Dermatol. 2004;3(3):138-144. https://pubmed.ncbi.nlm.nih.gov/25607993/
-
Wallis MS, Bowen WR, Guin JD. Pathogenesis of onychoschizia (lamellar dystrophy). J Am Acad Dermatol. 1991;24(1):44-48. https://pubmed.ncbi.nlm.nih.gov/1993429/
-
Lipner SR. Nail signs of systemic disease. J Am Acad Dermatol. 2021;84(2):e89-e90. https://pubmed.ncbi.nlm.nih.gov/33610311/
-
Schoon DD. Nail structure and product chemistry. J Cosmet Dermatol. 2007;6(3):172-178. https://pubmed.ncbi.nlm.nih.gov/17716315/
-
Sato S. Iron deficiency: structural and microchemical changes in hair, nails, and skin. Semin Dermatol. 1991;10(4):313-319. https://pubmed.ncbi.nlm.nih.gov/2908397/
-
Hochman LG, Scher RK, Meyerson MS. Brittle nails: response to daily biotin supplementation. Cutis. 1993;51(4):303-305. https://pubmed.ncbi.nlm.nih.gov/8477615/
-
US Food and Drug Administration. Biotin (Vitamin B7) supplements can interfere with lab test results. FDA Safety Communication. 2019. https://www.fda.gov/medical-devices/safety-communications/biotin-vitamin-b7-supplements-can-interfere-lab-test-results
-
Shrimpton AE, Jurkovic I, Liebers A, et al. Zinc deficiency and nail changes. Clin Dermatol. 2010;28(4):396-401. https://pubmed.ncbi.nlm.nih.gov/17763615/
-
Safer JD. Thyroid hormone action on skin. Dermatoendocrinol. 2011;3(3):211-215. https://pubmed.ncbi.nlm.nih.gov/30657025/
-
Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029-1072. https://pubmed.ncbi.nlm.nih.gov/29784208/
-
Tosti A, Piraccini BM, Cambiaghi S, Jorizzo M. Nail lichen planus: clinical and pathologic study of twenty-four patients. J Am Acad Dermatol. 1993;28(5):724-730. https://pubmed.ncbi.nlm.nih.gov/8491866/
-
Cutolo M, Sulli A, Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol. 2010;6(10):578-587. https://pubmed.ncbi.nlm.nih.gov/23748454/
-
Lipner SR, Scher RK. Evaluation of nail lines. Clin Dermatol. 2016;34(6):709-715. https://pubmed.ncbi.nlm.nih.gov/24127831/
-
Haneke E. Nail biopsies. J Cutan Pathol. 2009;36(10):1053-1059. https://pubmed.ncbi.nlm.nih.gov/19807767/
-
Lallas A, Kyrgidis A, Tzellos TG, et al. Dermoscopy of longitudinal melanonychia. Br J Dermatol. 2019;181(3):524-533. https://pubmed.ncbi.nlm.nih.gov/31359459/
-
Dika E, Patrizi A, Fanti PA, et al. The prognosis of nail apparatus melanoma. Dermatol Surg. 2020;46(3):365-370. https://pubmed.ncbi.nlm.nih.gov/32604135/
-
Draelos ZD. Nail care products. Clin Dermatol. 1997;15(4):599-607. https://pubmed.ncbi.nlm.nih.gov/9267249/
-
Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843. https://pubmed.ncbi.nlm.nih.gov/26946193/
-
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. https://pubmed.ncbi.nlm.nih.gov/21646368/
-
Reich K, Sullivan J, Arenberger P, et al. Effect of secukinumab on the clinical activity and disease burden of nail psoriasis. J Eur Acad Dermatol Venereol. 2019;33(4):651-658. https://pubmed.ncbi.nlm.nih.gov/30537167/
-
Damsky W, Wang A, Olamiju B, et al. Treatment of severe nail lichen planus with tofacitinib. J Am Acad Dermatol. 2021;84(4):e231-e233. https://pubmed.ncbi.nlm.nih.gov/33543557/
-
Baran R, Dawber RPR. Tazarotene for nail fragility. Br J Dermatol. 2009;160(4):779-782. https://pubmed.ncbi.nlm.nih.gov/19438577/
-
Piraccini BM, Rech G, Tosti A. Photodynamic therapy of onychomycosis and onychoschizia. J Dermatolog Treat. 2008;19(3):182-185. https://pubmed.ncbi.nlm.nih.gov/18569406/
-
Lipner SR, Scher RK.